Your Greatest Defense Is Within You
The future of cancer treatment is right here, right now. Precision targeted, uniquely personalized and remarkably effective. Because your greatest defense is within you.
Our Mission
Our sole mission is to bring a revolutionary immunotherapy to cancer patients unable to participate in ongoing FDA clinical trials.
What We Are
Targeted
Personalized
Natural
What We Aren’t
No Toxins
No Modified Cells
No Nonsense
What We Aren’t
No Toxins or Poisons
No Genetically Modified Cells
No Nonsense
The Origin of the IDCT
A Discovery in the Lab and Real World
In 2011, Matthew Halpert, Ph.D., joined a research team of cancer immunologists studying and developing a revolutionary approach to cancer treatment at Texas Medical Center. Dr. Halpert witnessed firsthand the powerful effects of this unique Dendritic Cell Treatment both in the laboratory and in real-world case studies.
This work has resulted in multiple, active FDA clinical trials studying the efficacy of this treatment. While this represents significant potential for cancer treatment, it did not help patients who did not qualify for the clinical trials.
The Future of Immunotherapy, Today
One Fundamental Treatment for Dozens of Cancer Situations
Unlike many alternative cancer centers, Immunocine only provides one fundamental treatment, a completely unique Dendritic Cell immunotherapy. It is a treatment that is unique to each patient and has worked across a variety of cancer types and stages. From Advanced Triple Negative Breast Cancer to Metastatic Prostate Cancer, our patients have seen incredible results despite being deemed refractory or incurable by their physicians.
Who We Are
Our team is comprised of some of the best and brightest medical and scientific minds in the US and Mexico.
Matthew Halpert, PhD
Founder and CEO
Stephen Noga, MD, PhD
Patient Oncology Advisor
Luis Ferbeyre, MD
Chief Oncologist
Rafael Gonzalez, PhD
Cell Therapy Advisor
Where We Are
Our cGMP-aligned, ISO-7 certified facility is one of the most advanced cell therapy facilities in Mexico.
Welcome to Paradise: Cancún
Until Double Loaded Dendritic Cells complete FDA Clinical Trials, it is only available overseas. Fortunately, Mexico offers broader treatment options for patients who don’t have time to wait.
For many, Medical Tourism is the best option to gain access to treatments that aren’t approved yet or to find lower-cost alternatives. Until now, our IDCT treatment has only been accessible to those participating in clinical trials.
Welcome to Paradise: Cancún
Until our treatment completes FDA Clinical Trials, it is only available overseas. Fortunately, Mexico offers broader treatment options for patients who don’t have time to wait.
For many, Medical Tourism is the best option to gain access to treatments that aren’t approved yet or to find lower-cost alternatives. Until now, our IDCT treatment has only been accessible to those participating in clinical trials.
State-of-the-Art Facilities & Service
Our cGMP-aligned, ISO-7 certified facility allows us to manufacture every treatment to ensure patient success and safety. All of our treatments are administered in fully licensed medical offices and/or Amerimed, which is an internationally accredited private hospital in Cancun. Cancun and its sophisticated healthcare infrastructure allow our team to provide this treatment and superior care simultaneously.
Clinical Validation
Immunocine’s Treatment is backed by decades of research, dozens of publications, multiple patents, and clinical successes.
Complete Medical Team
The team behind Immunocine consists of leading physcians and cancer immunologists to ensure the best treatment and care of each patient.
cGMP Clean Room
Our cGMP practicing, ISO-certified facility is one of the most advanced cell therapy facilities in Mexico and ensures the highest quality treatments for our patients.
